covid19
#SanofiActs
2020-03-30LL

First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

covid19
#SanofiActs
2020-03-27LL

Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19

When cancer grows old
#SanofiActs
2020-03-23LL

Sanofi Mobilizes to Develop a Vaccine against COVID-19

Q4 2019 results

Sanofi's Response in the Fight against COVID-19



Voices from the lab : Nadine Biesemann

5 Questions about Hydroxychloroquine and COVID-19

Paul Hudson image

Meeting the COVID-19 Challenge Together - Paul Hudson, CEO

 
COVID-19 Patient

COVID-19 Patient Resource Center

Real-World Evidence Turns Experience into Knowledge

2019 Integrated Report: Our Responsibility for the Future




  • Camera
    Press releases
    2020-04-06MMMM DD YYYY
    Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK